Concomitant p53 mutation and MYCN amplification in neuroblastoma

Reinaldo Manhani, Lílian Maria Cristófani, Vicente Odone Filho, Israel Bendit

Medical and Pediatric Oncology · 1997 · 17 citations · 24 references

Concepts

Abstract

The MYCN oncogene is amplified in 20% of childhood neuroblastoma and is associated independently with poor prognosis. Alteration of the p53 tumor supressor gene, in contrast, occurs infrequently in these tumors. In this report, we described a 3-year-old girl with stage IV neuroblastoma. Molecular analysis revealed, both MYCN gene amplification and a point mutation of the p53 tumor supressor gene. To our knowledge, this is the first reported case of neuroblastoma with genetic alterations of both these genes.

References

24